Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2021

07.08.2020 | Original Article

Clinical Profile and Severity of Hemolysis in Adult Patients of Primary Autoimmune Hemolytic Anemia and Their Response to Steroid: A Prospective Cohort Study from Single Institution

verfasst von: Gopal Krushna Ray, Debasish Mishra, Rabindra Kumar Jena, Smita Mahapatra, Sabita Palai, Ansuman Abhishek Parida

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Autoimmune hemolytic anaemia (AIHA) has traditionally been classified based on the temperature sensitivity of the autoagglutinins as warm (WAIHA), cold (CAIHA) and mixed type. Autoagglutinin may be of IgG or IgM type. The present prospective study was conducted to evaluate the profile of clinical picture, severity of haemolysis, treatment response of steroid. This study on patients of adult primary AIHA was conducted by taking complete history followed by detail physical examination. Laboratory investigations were performed to establish haemolytic anaemia and to assess severity of haemolysis. Immunehematological work up including blood grouping, direct antiglobulin test (DAT), IAT, antibody screening, adsorption elution was performed to diagnose type of AIHA. All cases were followed up to assess the response to prednisolone. All the data were collected and analysed by SPSS 19. Out of 62 primary AIHA cases, female were affected more than male (41:21). WAIHA is most common type (42, 67.8%) followed by mixed (20.9%) and cold AIHA (11.3%). Severity of haemolysis showed significant correlation with the DAT strength and not with type of AIHA. (P < 0.05) On oral prednisolone, 22 cases attended complete remission, while relapse, drug dependency and partial remission was achieved in 13, 9, 3 cases respectively. Severity of haemolysis in AIHA is directly related with DAT strength. WAIHA is most common type and can be managed with oral prednisolone (cr 45.2%), without red cell transfusion in most of cases. Mixed type AIHA cases were presented mostly with severe haemolysis, with minimum therapeutic response to prednisolone and maximum relapse/drug dependency.
Literatur
1.
Zurück zum Zitat De Gruchy GC (1989) The haemolytic anaemias. In: Firkin FC, Chesterman CN, Penington DG, Rush BM (eds) De Gruchy's clinical haematology in medical practice, 5th edn. Blckwell Science Ltd, Edinburgh, pp 172–215 De Gruchy GC (1989) The haemolytic anaemias. In: Firkin FC, Chesterman CN, Penington DG, Rush BM (eds) De Gruchy's clinical haematology in medical practice, 5th edn. Blckwell Science Ltd, Edinburgh, pp 172–215
2.
Zurück zum Zitat Dacie JV (1992) Autoimmunehemolytic anemia: pathogenesis. Thehemolytic anemia. 3rd edn. Churchill Livingstone, London, pp 392–451 Dacie JV (1992) Autoimmunehemolytic anemia: pathogenesis. Thehemolytic anemia. 3rd edn. Churchill Livingstone, London, pp 392–451
3.
Zurück zum Zitat Packman CH (2008) Hemolytic anemia due to warm autoantibodies. Blood Rev 22(1):17–31CrossRef Packman CH (2008) Hemolytic anemia due to warm autoantibodies. Blood Rev 22(1):17–31CrossRef
4.
Zurück zum Zitat Valent P, Lechner K (2008) Diagnosis and treatment of autoimmune hemolytic anemia in adults: a clinical review. Wien KlinWochenschr 120:136–151CrossRef Valent P, Lechner K (2008) Diagnosis and treatment of autoimmune hemolytic anemia in adults: a clinical review. Wien KlinWochenschr 120:136–151CrossRef
5.
Zurück zum Zitat Petz LD, Garratty G (1971) Classification and clinical characterization of Autoimmune hemolyticanemias. In: Acquired Immune HemolyticAnemias, 1st edn., p 28, Churchill Livingstone, New York Petz LD, Garratty G (1971) Classification and clinical characterization of Autoimmune hemolyticanemias. In: Acquired Immune HemolyticAnemias, 1st edn., p 28, Churchill Livingstone, New York
6.
Zurück zum Zitat Lechner K, Jager U (2010) How I treat autoimmune hemolytic anemia in adults. Blood 16:1831–1838CrossRef Lechner K, Jager U (2010) How I treat autoimmune hemolytic anemia in adults. Blood 16:1831–1838CrossRef
7.
Zurück zum Zitat Birgens H, Frederiksen H, Hasselbalch HC et al (2013) A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol 163(3):393–399CrossRef Birgens H, Frederiksen H, Hasselbalch HC et al (2013) A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol 163(3):393–399CrossRef
8.
Zurück zum Zitat Mishra D, Sahoo D, Ray GK, Panigrahi R (2018) Resolving serological blood group discrepancy and providing transfusion support in a patient of mixed autoimmune haemolytic anemia. HematoInt J 2(1):118 Mishra D, Sahoo D, Ray GK, Panigrahi R (2018) Resolving serological blood group discrepancy and providing transfusion support in a patient of mixed autoimmune haemolytic anemia. HematoInt J 2(1):118
9.
Zurück zum Zitat Wikman A, Axdorph U, Gryfelt G, Gustafsson L, Bjorkholm M, Lundhal J (2005) Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to invivohemolysis. Ann Hemato 84:150–158CrossRef Wikman A, Axdorph U, Gryfelt G, Gustafsson L, Bjorkholm M, Lundhal J (2005) Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to invivohemolysis. Ann Hemato 84:150–158CrossRef
10.
Zurück zum Zitat Wheeler CA, Calhoun L, Blackall DP (2004) Warm reactive autoantibodies: clinical and serological correlation. Am J clinical Patho 122:680–685CrossRef Wheeler CA, Calhoun L, Blackall DP (2004) Warm reactive autoantibodies: clinical and serological correlation. Am J clinical Patho 122:680–685CrossRef
11.
Zurück zum Zitat Das SS, Zaman RU, Safi M (2014) Incompatible blood transfusion: challenging yet life saving in the management of acute sever autoimmune haemolytic anemia. Asian J of Trans Scie 8(2):105–108CrossRef Das SS, Zaman RU, Safi M (2014) Incompatible blood transfusion: challenging yet life saving in the management of acute sever autoimmune haemolytic anemia. Asian J of Trans Scie 8(2):105–108CrossRef
12.
Zurück zum Zitat Garratty G, Petz LD (2002) Approaches to selecting blood for transfusion to patients with autoimmune hemolytic anemia. Transfusion 42:1390–1392CrossRef Garratty G, Petz LD (2002) Approaches to selecting blood for transfusion to patients with autoimmune hemolytic anemia. Transfusion 42:1390–1392CrossRef
13.
Zurück zum Zitat Sudulagunta SR, Kumbhat M, Sudulagunta MB (2017) Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management. J Hemato 6(1):12–20CrossRef Sudulagunta SR, Kumbhat M, Sudulagunta MB (2017) Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management. J Hemato 6(1):12–20CrossRef
14.
Zurück zum Zitat Pirofsky B (1976) Clinical aspects of autoimmune hemolytic anemia. Seminars Hematolo 13:251 Pirofsky B (1976) Clinical aspects of autoimmune hemolytic anemia. Seminars Hematolo 13:251
15.
Zurück zum Zitat Das SS, Nityanand S, Choudhary R (2009) Clinical and serological characterization of autoimmune hemolytic anemia in a tertiary care hospital in North India. AnnHemato 88:727–732 Das SS, Nityanand S, Choudhary R (2009) Clinical and serological characterization of autoimmune hemolytic anemia in a tertiary care hospital in North India. AnnHemato 88:727–732
16.
Zurück zum Zitat Allgood JW, Chaplin HJ (1967) Idiopathic acquiredautoimmunehemolytic anemia. Am J Med 43:254CrossRef Allgood JW, Chaplin HJ (1967) Idiopathic acquiredautoimmunehemolytic anemia. Am J Med 43:254CrossRef
17.
Zurück zum Zitat Schreiber AD, Herskovitz BS, Goldwein M (1977) Low-titer cold hemagglutinin disease, mechanism of haemolysis and response to corticosteroid. N Eng J Medicine 296:1490–1494CrossRef Schreiber AD, Herskovitz BS, Goldwein M (1977) Low-titer cold hemagglutinin disease, mechanism of haemolysis and response to corticosteroid. N Eng J Medicine 296:1490–1494CrossRef
18.
Zurück zum Zitat Bianco C, Grifin FM, Silverstein SC (1975) Studies of the macrophage complement receptor. J Exp Med 141:1278CrossRef Bianco C, Grifin FM, Silverstein SC (1975) Studies of the macrophage complement receptor. J Exp Med 141:1278CrossRef
19.
Zurück zum Zitat Mahapatra S, Sahoo D, Patajoshi S, Sahu A, Parida P, Mishra S (2012) Distribution and prevalence of ABO and Rh phenotype blood groups in eastern India. J Pharm Biomed Sci 04:712–714 Mahapatra S, Sahoo D, Patajoshi S, Sahu A, Parida P, Mishra S (2012) Distribution and prevalence of ABO and Rh phenotype blood groups in eastern India. J Pharm Biomed Sci 04:712–714
20.
Zurück zum Zitat Mishra D, Parida P, Mahapatra S, Sahu BB (2018) Resolving blood group discrepancy in patients of a tertiary care centre in Odisha, India. Int J Res Med Sci 6(2):2348–2353CrossRef Mishra D, Parida P, Mahapatra S, Sahu BB (2018) Resolving blood group discrepancy in patients of a tertiary care centre in Odisha, India. Int J Res Med Sci 6(2):2348–2353CrossRef
21.
Zurück zum Zitat Settipane GA, Pudupakkam RK, McGowan JH (1978) Corticosteroid effect on immunoglobulins. J Allergy ClinImmunol 62(3):162–166CrossRef Settipane GA, Pudupakkam RK, McGowan JH (1978) Corticosteroid effect on immunoglobulins. J Allergy ClinImmunol 62(3):162–166CrossRef
Metadaten
Titel
Clinical Profile and Severity of Hemolysis in Adult Patients of Primary Autoimmune Hemolytic Anemia and Their Response to Steroid: A Prospective Cohort Study from Single Institution
verfasst von
Gopal Krushna Ray
Debasish Mishra
Rabindra Kumar Jena
Smita Mahapatra
Sabita Palai
Ansuman Abhishek Parida
Publikationsdatum
07.08.2020
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2021
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01326-4

Weitere Artikel der Ausgabe 1/2021

Indian Journal of Hematology and Blood Transfusion 1/2021 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.